Omadacycline

(Nuzyra®)

Nuzyra®

Drug updated on 11/16/2023

Dosage FormInjection (intravenous; 100 mg) Tablet (oral; 150 mg)
Drug ClassTetracycline class antibacterials
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of adult patients with community-acquired bacterial pneumonia (CABP) caused by susceptible microorganisms.
  • For the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible microorganisms.